1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311-21. [ DOI:10.1016/j.diabres.2011.10.029] [ PMID] 2. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (†). Ann Med. 2017;49(2):106-16. [ DOI:10.1080/07853890.2016.1231932] [ PMID] 3. Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, et al. Diabetic foot ulcers: Part I. Pathophysiology and prevention. J Am Acad Dermatol. 2014;70(1):1.e-18; quiz 9-20. [ DOI:10.1016/j.jaad.2013.06.055] [ PMID] 4. Yu JH, Hwang JY, Shin MS, Jung CH, Kim EH, Lee SA, et al. The prevalence of peripheral arterial disease in korean patients with type 2 diabetes mellitus attending a university hospital. Diabetes Metab J. 2011;35(5):543-50. [ DOI:10.4093/dmj.2011.35.5.543] [ PMID] [ ] 5. Desormais I, Aboyans V, Bura A, Constans J, Cambou JP, Messas E, et al. Anemia, an independent predictive factor for amputation and mortality in patients hospitalized for peripheral artery disease. Eur J Vasc Endovasc Surg. 2014;48(2):202-7. [ DOI:10.1016/j.ejvs.2014.04.005] [ PMID] 6. Sterner G, Carlson J, Ekberg G. Raised platelet levels in diabetes mellitus complicated with nephropathy. J Intern Med. 1998;244(6):437-41. [ DOI:10.1111/j.1365-2796.1998.00349.x] [ PMID] 7. Bao K, Huang H, Huang G, Wang J, Liao Y, Pan Y, et al. Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure. BMC Cardiovasc Disord. 2021;21(1):618. [ DOI:10.1186/s12872-021-02423-6] [ PMID] [ ] 8. Işık F, Soner S. Platelet-to-Hemoglobin Ratio Is an Important Predictor of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction. Cureus. 2022;14(7):e26833. [ DOI:10.7759/cureus.26833] 9. Ozbeyaz NB, Gokalp G, Algul E, Sahan HF, Aydinyilmaz F, Guliyev I, et al. Platelet-hemoglobin ratio predicts amputation in patients with below-knee peripheral arterial disease. BMC Cardiovasc Disord. 2022;22(1):337. [ DOI:10.1186/s12872-022-02788-2] [ PMID] [ ] 10. Mardia AI, Gatot D, Lindarto D, editors. Comparison platelet indices in diabetic patients with and without diabetic foot ulcer2018: IOP Publishing. [ DOI:10.1088/1755-1315/125/1/012134] 11. Saluja S, Anderson SG, Hambleton I, Shoo H, Livingston M, Jude EB, et al. Foot ulceration and its association with mortality in diabetes mellitus: a meta‐analysis. Diabetic Medicine. 2020;37(2):211-8. [ DOI:10.1111/dme.14151] [ PMID] 12. Yammine K, Hayek F, Assi C. Is there an association between anemia and diabetic foot ulcers? A systematic review and meta‐analysis. Wound Repair and Regeneration. 2021;29(3):432-42. [ DOI:10.1111/wrr.12902] [ PMID] 13. Babaei V, Afradi H, Gohardani H, Nasseri F, Azarafza M, Teimourian S. Management of chronic diabetic foot ulcers using platelet-rich plasma. Journal of wound care. 2017;26(12):784-7. [ DOI:10.12968/jowc.2017.26.12.784] [ PMID] 14. Orban YA, Soliman MA, Hegab YH, Alkilany MM. Autologous platelet-rich plasma vs conventional dressing in the management of chronic diabetic foot ulcers. Wounds: A Compendium of Clinical Research and Practice. 2022;33(2):36-42. [ DOI:10.25270/wnds/2022.3642] [ PMID] 15. Izzo P, De Intinis C, Molle M, Polistena A, Sibio S, Codacci-Pisanelli M, et al. Case report: The use of PRP in the treatment of diabetic foot: case series and a review of the literature. Frontiers in Endocrinology. 2023;14:1286907. [ DOI:10.3389/fendo.2023.1286907] [ PMID] [ ] 16. Wahyuningsih KA, Sobariah S, Rosliana I, Rosadi I, Widyastuti T, Afini I, et al. Evaluation of platelet-rich plasma from diabetic donors shows increased platelet vascular endothelial growth factor release. Stem cell investigation. 2019;6:43. [ DOI:10.21037/sci.2019.10.02] [ PMID] [ ] 17. Ferreiro JL, Gómez-Hospital JA, Angiolillo DJ. Platelet abnormalities in diabetes mellitus. Diabetes and vascular disease research. 2010;7(4):251-9. [ DOI:10.1177/1479164110383994] [ PMID] 18. Mineoka Y, Ishii M, Hashimoto Y, Yamashita A, Nakamura N, Fukui M. Platelet to lymphocyte ratio correlates with diabetic foot risk and foot ulcer in patients with type 2 diabetes. Endocrine journal. 2019;66(10):905-13. [ DOI:10.1507/endocrj.EJ18-0477] [ PMID] 19. Schneider DJ. Factors contributing to increased platelet reactivity in people with diabetes. Diabetes care. 2009;32(4):525-7. [ DOI:10.2337/dc08-1865] [ PMID] [ ] 20. Mas' ud A, Najman N. Hubungan Kadar Hemoglobin (Hb) Dengan Derajat Diabetic Foot Ulcers (DFU) Di Kabupaten Bone. Jurnal Keperawatan Muhammadiyah. 2022;7(4). [ DOI:10.30651/jkm.v7i4.15085] 21. Li S, Bian S, Wang H, Li H, Peng G, Guo L. Platelet/hemoglobin ratio predicts severity of diabetic foot ulcer: a report of 345 cases. Journal of Army Medical University. 2024;46(9):1057-62, F3. 22. Pratiwi MP, Syakdiyah NH, Sintoro HP. Platelet-to-lymphocyte ratio (PLR), platelet-to-hemoglobin ratio (PHR) and systemic immune-inflammation index (SII) as predictive factors of amputation among Diabetic Foot Ulcer (DFU) in Ibnu Sina Gresik Regional Public Hospital, East Java, Indonesia. Indonesia Journal of Biomedical Science. 2024;18(1):158-61. [ DOI:10.15562/ijbs.v18i1.570] 23. Gunes AE, Eren MA, Karakas EY, Demir M, Aslan HK, Sabuncu T. Relation with mean platelet volume and diabetic foot ulcers. Acta Medica Mediterranea. 2017;33:401.
|
.gif){kind=logo}
